AI is enabling vital new directions for medical research. Intelligent algorithms are driving innovation in drug discovery, precision medicine and medical imaging. By harnessing the IPU, healthcare innovators can take full advantage of these new approaches. Next generation models can be run with unprecedented speed and accuracy, helping research scientists to deliver breakthroughs with potentially life-saving results.
Graphcore IPUs provide flexibility that allows researchers to use new and complex models which can help them improve decision-making about patient health and derive insights faster, detect diseases earlier, and expedite future cures even faster.
The recent explosion in big data has huge potential to advance medical research. But extracting value from unstructured information remains a challenge. The IPU's flexibility allows researchers to use new and complex models which can help them improve decision-making about patient health and derive insights faster.
Detecting anomalies to pinpoint a diagnosis can be lengthy, painstaking work. Thanks to the IPU’s state of the art performance, researchers can now leverage new AI algorithms to accelerate the diagnostic process, build cutting-edge models and optimise treatment.
With time to market for new drugs taking as long as a decade, AI is driving much needed acceleration in the development pipeline. With its accelerated compute, the IPU can be harnessed to expedite drug discovery and advance pharmaceutical research.
The rising adoption of DNA sequencing is enhancing our understanding of patient treatment. By utilising genomic data, researchers can work to improve health outcomes. The IPU enables new approaches to machine intelligence which can accelerate DNA sequencing and advance genomic medicine.
Interested in finding out if Graphcore IPUs can help your company with medical imaging, research, drug development, and precision medicine? See if you qualify for a free trial today by clicking the button below and filling out the form.